Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.
A group of US hospitals has expanded use of insulin therapy management software to all its acute care facilities, to improve best practices and reduce risk of hyperglycaemia and hypoglycaem
Babylon Healthcare's roll-out of its online doctor service beyond London have hit a snag after it emerged the NHS wants to launch a year-long independent evaluation of the service.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.